Epsiprantel is a compound of defined chemical structure and pharmaceutical significance whose toxicological characterisation supports health-based exposure limit derivation for pharmaceutical manufacturing occupational safety and cross-contamination control. The relationship between molecular structure and biological potency—assessed through structure-activity relationship analysis and experimental pharmacological and toxicological data—determines the OEB classification and the engineering containment requirements governing manufacturing operations involving Epsiprantel.
Interspecies uncertainty factor F1 refinement for Epsiprantel is achievable when comparative toxicokinetic data characterise the AUC ratio between humans and the test species at relevant doses, replacing the default allometric scaling assumption. If the human AUC at the oral equivalent of the animal NOAEL dose exceeds the animal AUC—indicating greater human systemic exposure per unit dose—the F1 value is increased bey
